Shuichi Fujimoto - My portal - researchmap

Profile Information

Affiliation: Head, Division of Chemotherapy, Chiba Cancer Center (Research Institute)

Degree: Doctor of Pharmacy(Tohoku University)

J-GLOBAL ID: 200901054005378061
researchmap Member ID: 0000032292

External link: http://www.chiba-cc.jp/

Research Interests

4

Research Areas

1

Life sciences / Pharmacology /

Research History

6

1984 - 2008

Chiba Cancer Center
1984 - 2008

Division of Chemotherapy, Chiba Cancer Center
1973 - 1984

(財)癌研究会･癌化学療法センター臨床研究部
1973 - 1984

Division of Clinical Chemotherapy, Cancer
Research Institute
Chemotherapy Center, Japanese Foundation for Cancer Research

Education

4

Committee Memberships

4

1997 - 2009

評議員, 日本癌学会
1997 - 2009

councilor, the Japan Cancer Association
1999 - 2000

評議員, 日本癌治療学会
1999 - 2000

councilor, the Japan Society of Clinical Oncology

Misc.

17

Promising antitumor activity of a novel quinoline derivative, TAS-103, against fresh clinical specimens of eight types of tumors measured by flow cytometric DNA analysis

Shuichi Fujimoto

Biol Pharm Bull, 30(10) 1923-1929, 2007
Promising antitumor activity of a novel quinoline derivative, TAS-103, against fresh clinical specimens of eight types of tumors measured by flow cytometric DNA analysis

Shuichi Fujimoto

Biol. Pharm. Bull., 30(10) 1923-1929, 2007
Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice

Shuichi Fujimoto

Biological and Pharmaceutical Bulletin, 29(11) 2260-2266, Nov, 2006
Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice

Shuichi Fujimoto

Biol Pharm Bull, 29(11) 2260-2266, 2006
Trastuzumab (Herceptin) の適応決定にFISH法はどこまで必要か？

癌の臨床, 51, 257-263, 2005
脳腫瘍の診断と治療ー最新の研究動向ー VI. 脳腫瘍の治療化学療法感受性試験に基づく化学療法

日本臨床, 63, 456-459, 2005
Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas

Int J Oncol, 26, 993-998, 2005
Proteome-based identification of molecula markers predicting chemosensitivity to each category of anticancer agents in human gliomas

Int. J. Oncol., 26, 993-998, 2005
Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing

Y Iwadate, S Fujimoto, H Namba, A Yamaura

BRITISH JOURNAL OF CANCER, 89(10) 1896-1900, Nov, 2003
Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing

Y Iwadate, S Fujimoto, H Namba, A Yamaura

BRITISH JOURNAL OF CANCER, 89(10) 1896-1900, Nov, 2003
Differential Chemosensitivity in Human Intracereboral Gliomas Measared by Flow Cytometric DNA Analysis

Int. J. Molecular Medicine, 10, 187-192, 2002
Alteration of CDKN2/p16 in human astrocytic tumors is related with increased sasceptibility to antimetabolite anticancer agents

Int. J. of Oncol., 17, 501-505, 2002
Differential Chemosensitivity in Human Intracereboral Gliomas Measared by Flow Cytometric DNA Analysis

Int. J. Molecular Medicine, 10, 187-192, 2002
プロテオミクスによるグリオーマ薬剤感受性規定因子の検索

Neuro-Oncology, 11, 88-92, 2001
Association of p53 gene mutations with sensitivity to TZT-1027 in patients with clinical lung and renal carcinoma

Cancer(2001), 92, 386-394, 2001
Association of p53 gene mutations with sensitivity to TZT-1027 in patients with clinical lung and renal carcinoma

Cancer(2001), 92, 386-394, 2001
Alteration of CDKN2/p16 in human astrocytic tumors is related with increased sasceptibility to antimetabolite anticancer agents

Int. J. of Oncol., 17, 501-505, 2000

Professional Memberships

6

Research Projects

4

抗癌剤感受性試験、新規抗癌剤の開発

1984 - 2004
Chemosensitivity test for human malignancies, Development of New antitumor agents

1984 - 2004
がんのトランスレーショナルリサーチ

2004
Translational research of cancers

2004